Today: 7 February 2026
Subscribe

Uber Stock (NYSE: UBER) on Dec. 23, 2025: Robotaxi Momentum Meets FTC Lawsuit Risk as Wall Street Reprices the Story

Uber Stock (NYSE: UBER) on Dec. 23, 2025: Robotaxi Momentum Meets FTC Lawsuit Risk as Wall Street Reprices the Story

Uber Technologies, Inc. (NYSE: UBER) is back at the center of the autonomous-vehicle debate heading into year-end trading, with investors weighing a fresh robotaxi catalyst in the U.K. against intensifying regulatory scrutiny in the U.S. As of Tuesday, December 23, 2025, Uber shares were trading around $80.52, down about 0.9% on the day after an intraday high near $81.67. With the stock hovering in the low $80s, Uber’s equity value remains in the “mega-cap-adjacent” tier, with market-cap estimates clustering around ~$170 billion depending on the data source and timestamp. Nasdaq+1 What’s driving the tape isn’t a single metric—it’s a narrative
23 December 2025
·····
Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble (The Procter & Gamble Company, ticker PG) is closing out 2025 with its stock hovering near the lower half of its 52-week range—an area that’s attracting fresh attention from analysts and long-term dividend investors alike. As of December 23, 2025, PG shares are trading around $143.6, up modestly on the day after Monday’s pullback, with investors now looking ahead to two near-term catalysts: a CEO transition on January 1, 2026, and the company’s fiscal Q2 2025/26 earnings event on January 22, 2026. Barron’s+1 Below is a comprehensive roundup of the latest PG stock news, forecasts, and analysis
23 December 2025
·····
Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Inc. (NYSE: V) stock is back in the spotlight on Dec. 23, 2025, as fresh holiday spending data adds new color to the consumer-demand picture—and as investors weigh the payments giant’s fast-moving strategy in stablecoin settlement and AI-driven “agentic commerce.” As of early afternoon Tuesday, Visa shares were modestly higher, trading around $354 (roughly +0.5% on the day), with the company’s investor relations quote page listing a 52-week range of about $299 to $375. Visa Investor Relations Below is what’s driving headlines around Visa stock today, plus the forecasts and key debates shaping the outlook into 2026. Visa stock
23 December 2025
····
ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

December 23, 2025 — Shares of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) jumped Tuesday after the company disclosed that its board has received multiple competing proposals to acquire the company’s outstanding shares, escalating a strategic review that has been underway for months. ZIM Investors+2Benzinga+2 As of 17:15 UTC on Tuesday, Dec. 23, ZIM traded at $20.96, after touching an intraday high of $22.35 and low of $20.72 on unusually heavy volume. What’s driving the move is simple in headline form—“buyout proposals”—but the investor calculus is more complicated: ZIM sits at the intersection of (1) a potentially high-stakes corporate event
23 December 2025
····
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

Dec. 23, 2025 — NexGen Energy Ltd. (TSX: NXE | NYSE: NXE | ASX: NXG) is back in the spotlight as investors weigh a familiar uranium-developer question with very unfamiliar stakes: how close is “close” to a construction decision? TMX Newsfile+1 For NexGen, that question largely funnels into one major catalyst: the Canadian Nuclear Safety Commission (CNSC) process for its 100%-owned Rook I Project in Saskatchewan’s uranium-rich Athabasca Basin. Part 1 of the CNSC hearing took place on Nov. 19, 2025, and Part 2 is scheduled for Feb. 9–13, 2026, after which the Commission will make its approval determination. Canadian
23 December 2025
·······
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next. What is Structure Therapeutics, and why does GPCR trade like a headline detector? Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule
23 December 2025
·····
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. (NYSE: MRK) is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK stock is being evaluated not just on quarterly numbers—but on whether Merck can extend growth beyond Keytruda while navigating intensifying U.S. drug-pricing scrutiny. Reuters+2Reuters+2 Below is a comprehensive, publication-ready roundup of today’s MRK stock action, the key news moving the
23 December 2025
·····
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation (NYSE: BAC) stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report. As of Tuesday, December 23, 2025, BAC was trading around $55.96, modestly higher on the session, after touching an intraday high near $56.17. Investing.com Below is a full round-up of the latest news, forecasts, and market analysis available as of 23.12.2025, plus the key catalysts that could decide whether Bank of America stock breaks
23 December 2025
·····
Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp (NASDAQ: HUT; TSX: HUT) is back in the market’s spotlight on December 23, 2025, as investors continue to re-rate the company less like a pure-play Bitcoin miner and more like a power-and-data-center platform for the AI era. The stock’s action has been anything but sleepy. After opening sharply lower, shares reversed higher and pushed into the low-to-mid $50s intraday. As of 17:04 UTC on Dec. 23, Hut 8 traded at $53.62, up 6.41% on the day, with an intraday range of $48.02 to $53.86 on roughly 6.7 million shares. So what’s driving the whiplash—and why are analysts
23 December 2025
······
Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Corporation (NASDAQ: INTC) is ending 2025 in a familiar place for long-time investors—right at the center of a high-stakes debate about what Intel is supposed to be. Is it a classic CPU giant fighting to regain product leadership? A U.S.-anchored foundry champion meant to rival TSMC? Or both at once? On Tuesday, Dec. 23, 2025, that identity question is colliding with a fresh wave of Wall Street calls, a closely watched Nvidia investment now cleared by U.S. antitrust agencies, and renewed arguments that Intel’s foundry ambitions may be limited by one simple issue: trust. Reuters+2Fudzilla+2 Intel stock price today:
23 December 2025
·····
Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

December 23, 2025 — Lionsgate Studios Corp stock is having a loud day in the market. Shares of Lionsgate Studios Corp (NYSE: LION) traded around $9.06 Tuesday, up roughly 8%–9%, after touching an intraday high near $9.23 (and a low around $8.54). That price action matters because LION has been flirting with (and now pushing beyond) its prior 52-week high around $9.14—a technical milestone that tends to attract momentum traders and forces skeptics to revisit the “this is just a sleepy studio stock” thesis. Lionsgate Investors+1 Below is what’s new as of Dec. 23, 2025, plus the most relevant forecasts
23 December 2025
·····
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock (NYSE: LLY) is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval. As of 15:11 UTC on Tuesday, LLY traded around $1,077, slightly above the prior close, after moving between roughly $1,057 and $1,088 during the session. The backdrop is simple but powerful: the obesity market is expanding fast, and the “next chapter” is about convenience, supply,
23 December 2025
·····
1 … 1,289 1,290 1,291 1,292 1,293 … 2,708

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop